Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-4 av 4

2019
1 Flem-Karlsen, Karine; Tekle, Christina; Øyjord, Tove Ragnhild; Flørenes, Vivi Ann; Mælandsmo, Gunhild Mari; Fodstad, Øystein; Nunes-Xavier, Caroline Elisabeth.
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance. Scientific Reports 2019 ;Volum 9.(1)
UiT UiO OUS Untitled
 
2 Flørenes, Vivi Ann; Flem-Karlsen, Karine; McFadden, Erin; Bergheim, Inger Riise; Nygaard, Vigdis; Nygård, Vegard Mokleiv; Farstad, Inger Nina; Øy, Geir Frode; Emilsen, Elisabeth; Fleten, Karianne Giller; Ree, Anne Hansen; Flatmark, Kjersti; Gullestad, Hans Petter; Hermann, Robert; Ryder, Truls; Wernhoff, Patrik; Mælandsmo, Gunhild Mari.
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases. Translational Oncology 2019 ;Volum 12.(7) s. 951-958
UiO OUS AHUS UiT Untitled
 
3 Juraleviciute, Marina; Pozniak, Joanna; Nsengimana, Jérémie; Harland, Mark; Randerson-Moor, Juliette; Vernhoff, Patrik; Bassarova, Assia Vassileva; Øy, Geir Frode; Trøen, Gunhild; Flørenes, Vivi Ann; Bishop, David Timothy; Herlyn, Meenhard; Newton-Bishop, Julia; Slipicevic, Ana.
MX 2 is a novel regulator of cell cycle in melanoma cells. Pigment Cell & Melanoma Research 2019
OUS Untitled
 
4 Karlsen, Karine Flem; McFadden, Erin; Omar, Nasrin; Haugen, Mads Haugland; Øy, Geir Frode; Ryder, Truls; Gullestad, Hans Petter; Hermann, Robert; Mælandsmo, Gunhild Mari; Flørenes, Vivi Ann.
Targeting AXL and the DNA damage response pathway as a novel therapeutic strategy in melanoma. Molecular Cancer Therapeutics 2019 ;Volum 19.(3) s. 895-905
OUS UiO Untitled